Position in GILD
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$2,063,384
-$123,749 QoQ
Shares Held
16,332
+4.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.57%
of 13F equity value
Holder Rank
#821
of 2,266 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Old Port Advisors holds $21,158,060 across 12 Drug Manufacturers - General names. GILD ranks #5 (9.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GSK |
GSK plc
|
69,539 | $3,645,234 | |
| 2 | NVS |
Novartis AG
|
21,266 | $3,332,807 | |
| 3 | PFE |
Pfizer Inc
|
114,101 | $2,747,552 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
36,348 | $2,094,371 | |
| 5 | GILD |
Gilead Sciences, Inc.
This page
|
16,332 | $2,063,384 | |
| 6 | SNY |
Sanofi
|
48,080 | $2,051,092 | |
| 7 | LLY |
ELI LILLY & Co
|
1,253 | $1,502,885 | |
| 8 | JNJ |
Johnson & Johnson
|
5,683 | $1,443,311 |
All Filings in GILD
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,063,384 | 16,332 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $2,187,133 | 15,693 | Shares | Sole | 2026-04-06 | |
| 2025-12-31 | $1,694,180 | 13,803 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $1,188,144 | 10,704 | Shares | Sole | 2025-10-06 | |
| 2025-06-30 | $811,679 | 7,321 | Shares | Sole | 2025-07-16 | |
| No filing history on record for this holder in this stock. | ||||||